Amarin Pharma, Inc. (United States)

Amarin Corporation is a pharmaceutical company focused on cardiovascular health. The company developed VASCEPA (icosapent ethyl), an FDA-approved prescription omega-3 fatty acid therapy derived from fish oil. VASCEPA is indicated to reduce cardiovascular risk in patients with elevated triglycerides and established cardiovascular disease or diabetes. Amarin’s innovative lipid-regulating therapy helps prevent heart attacks, strokes, and cardiovascular death in high-risk patients.